A PHASE 1, RANDOMIZED, OPEN-LABEL, SINGLE-CENTER COMPARISON OF HETEROLOGOUS PRIME-BOOST VACCINATION SCHEDULES OF TETRAVALENT DENGUE VIRUS PURIFIED INACTIVATED VACCINE (PIV) AND TETRAVALENT DENGUE VIRUS LIVE ATTENUATED VACCINE (LAV) IN HEALTHY ADULTS IN A NONENDEMIC REGION THROUGH 28 DAYS POST VACCINATION
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined